RE:Upcoming valuation on a jv dealWhen we will see a follow thru and action on the JV sude is the question. Was hopeful after they added a new director a couple months ago. Since radio silence!
Just a reminder:
Dr. Lbiati is an internationally trained medical doctor, who utilizes her extensive clinical and business background to assist biopharmaceutical organizations to achieve their strategic objectives through: systematic achievement of their value inflection milestones, partnering of their promising drug candidates with large international pharmaceutical companies and ultimately increasing shareholder value.